MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
366.58
+1.93
+0.53%
After Hours: 366.75 +0.17 +0.05% 18:46 02/11 EST
OPEN
365.14
PREV CLOSE
364.65
HIGH
368.51
LOW
361.00
VOLUME
2.83M
TURNOVER
--
52 WEEK HIGH
385.12
52 WEEK LOW
255.23
MARKET CAP
197.40B
P/E (TTM)
25.77
1D
5D
1M
3M
1Y
5Y
1D
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings
NASDAQ · 8h ago
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52
Simply Wall St · 11h ago
Dow Movers: AMGN, DIS
NASDAQ · 1d ago
Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend
Simply Wall St · 1d ago
Gilead Sciences: Buy This Stock For Both Dividend And Growth
Seeking Alpha · 1d ago
FDA Approves UPLIZNA for Adults With Anti-AChR or Anti-MuSK Antibody Positive Generalized Myasthenia Gravis
Reuters · 2d ago
FDA lässt UPLIZNA von Amgen zur Behandlung von gMG zu
Reuters · 2d ago
Amgen, Merck share losses contribute to Dow's 200-point drop
MarketWatch · 2d ago
More
About AMGN
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.